BACKGROUND: The importance of Q fever, spotted fever group rickettsiosis (SFGR), and typhus group rickettsiosis (TGR) as causes of febrile illness in sub-Saharan Africa is unknown; the putative role of Q fever as a human immunodeficiency virus (HIV) coinfection is unclear. METHODS: We identified febrile inpatients in Moshi, Tanzania, from September 2007 through August 2008 and collected acute- and convalescent-phase serum samples. A ≥4-fold increase in immunoglobulin (Ig) G immunfluorescence assay (IFA) titer to Coxiella burnetii phase II antigen defined acute Q fever. A ≥4-fold increase in IgG IFA titer to Rickettsia conorii or Rickettsia typhi antigen defined SFGR and TGR, respectively. RESULTS: Among 870 patients, 483 (55.5%) were tested for acute Q fever, and 450 (51.7%) were tested for acute SFGR and TGR. Results suggested acute Q fever in 24 (5.0%) patients and SFGR and TGR in 36 (8.0%) and 2 (0.5%) patients, respectively. Acute Q fever was associated with hepato- or splenomegaly (odds ratio [OR], 3.1; P = .028), anemia (OR, 3.0; P = .009), leukopenia (OR, 3.9; P = .013), jaundice (OR, 7.1; P = .007), and onset during the dry season (OR, 2.7; P = .021). HIV infection was not associated with acute Q fever (OR, 1.7; P = .231). Acute SFGR was associated with leukopenia (OR, 4.1; P = .003) and with evidence of other zoonoses (OR, 2.2; P = .045). CONCLUSIONS: Despite being common causes of febrile illness in northern Tanzania, Q fever and SFGR are not diagnosed or managed with targeted antimicrobials. C. burnetii does not appear to be an HIV-associated co-infection.
BACKGROUND: The importance of Q fever, spotted fever group rickettsiosis (SFGR), and typhus group rickettsiosis (TGR) as causes of febrile illness in sub-Saharan Africa is unknown; the putative role of Q fever as a human immunodeficiency virus (HIV) coinfection is unclear. METHODS: We identified febrile inpatients in Moshi, Tanzania, from September 2007 through August 2008 and collected acute- and convalescent-phase serum samples. A ≥4-fold increase in immunoglobulin (Ig) G immunfluorescence assay (IFA) titer to Coxiella burnetii phase II antigen defined acute Q fever. A ≥4-fold increase in IgG IFA titer to Rickettsia conorii or Rickettsia typhi antigen defined SFGR and TGR, respectively. RESULTS: Among 870 patients, 483 (55.5%) were tested for acute Q fever, and 450 (51.7%) were tested for acute SFGR and TGR. Results suggested acute Q fever in 24 (5.0%) patients and SFGR and TGR in 36 (8.0%) and 2 (0.5%) patients, respectively. Acute Q fever was associated with hepato- or splenomegaly (odds ratio [OR], 3.1; P = .028), anemia (OR, 3.0; P = .009), leukopenia (OR, 3.9; P = .013), jaundice (OR, 7.1; P = .007), and onset during the dry season (OR, 2.7; P = .021). HIV infection was not associated with acute Q fever (OR, 1.7; P = .231). Acute SFGR was associated with leukopenia (OR, 4.1; P = .003) and with evidence of other zoonoses (OR, 2.2; P = .045). CONCLUSIONS: Despite being common causes of febrile illness in northern Tanzania, Q fever and SFGR are not diagnosed or managed with targeted antimicrobials. C. burnetii does not appear to be an HIV-associated co-infection.
Authors: G C Gray; G R Rodier; V C Matras-Maslin; M A Honein; E A Ismail; B A Botros; A K Soliman; B R Merrell; S P Wang; J T Grayston Journal: Am J Trop Med Hyg Date: 1995-04 Impact factor: 2.345
Authors: Lucy M Ndip; Eric B Fokam; Donald H Bouyer; Roland N Ndip; Vincent P K Titanji; David H Walker; Jere W McBride Journal: Am J Trop Med Hyg Date: 2004-09 Impact factor: 2.345
Authors: L Bélec; G Grésenguet; M T Ekala; A Jacob; M D Vohito; S Cotigny; C Payan Journal: Eur J Clin Microbiol Infect Dis Date: 1993-10 Impact factor: 3.267
Authors: Philippe Parola; Christopher D Paddock; Cristina Socolovschi; Marcelo B Labruna; Oleg Mediannikov; Tahar Kernif; Mohammad Yazid Abdad; John Stenos; Idir Bitam; Pierre-Edouard Fournier; Didier Raoult Journal: Clin Microbiol Rev Date: 2013-10 Impact factor: 26.132
Authors: Katherine C Horton; Ju Jiang; Alice Maina; Erica Dueger; Alia Zayed; Ammar Abdo Ahmed; Guillermo Pimentel; Allen L Richards Journal: Am J Trop Med Hyg Date: 2016-06-06 Impact factor: 2.345
Authors: Halie K Miller; Loredana Santo; M Constanza Camargo; Cheryl A Winkler; James J Goedert; Gilbert J Kersh; Charles S Rabkin Journal: Blood Date: 2017-04-10 Impact factor: 22.113
Authors: S P Fiorillo; H C Diefenthal; P C Goodman; H O Ramadhani; B N Njau; A B Morrissey; V P Maro; W Saganda; G D Kinabo; M S Mwako; J A Bartlett; J A Crump Journal: Clin Radiol Date: 2013-06-26 Impact factor: 2.350
Authors: Maria Angélica M M Mares-Guia; Tatiana Rozental; Alexandro Guterres; Michelle Dos Santos Ferreira; Renato De Gasperis Botticini; Ana Kely Carolina Terra; Sandro Marraschi; Rosany Bochner; Elba R S Lemos Journal: Am J Trop Med Hyg Date: 2016-02-29 Impact factor: 2.345
Authors: Heidi Wood; Michael A Drebot; Eric Dewailly; Liz Dillon; Kristina Dimitrova; Martin Forde; Allen Grolla; Elise Lee; Amanda Loftis; Kai Makowski; Karen Morrison; Lyndon Robertson; Rosina C Krecek Journal: Am J Trop Med Hyg Date: 2014-06-09 Impact factor: 2.345